Ray Shiao is an accomplished finance leader with extensive experience in financial planning and analysis (FP&A). Currently serving as Executive Director of FP&A at Entrada Therapeutics since April 2023, Ray previously held the role of Senior Director and Director of FP&A at Evelo Biosciences from October 2019 to April 2023. Prior to that, Ray worked at Sunovion Pharmaceuticals for nearly nine years in various finance roles, including Associate Director of Finance and Sr. Manager of FP&A. Ray's career began at Sun Microsystems, where a range of positions from Financial Consultant to Senior Financial Analyst were held over more than a decade. Ray holds an MBA from Boston College Carroll School of Management and a B.S. in Finance, Information Systems, and Japanese from Santa Clara University.